NIH-funded research R01 grant

Investigating the role of a protein in blood vessel function related to Alzheimer's disease

Official title: Role of Sox18 in neurovascular dysfunction in Alzheimer's disease

Funded at University of California, San Diego · NIH-11029187 · Data updated 2026-11-12

This study is looking at how problems with blood vessels in the brain might affect Alzheimer's disease, specifically focusing on a protein called Sox18, to help find new ways to improve brain health for people living with Alzheimer's.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Diego
NIH-funded
Lab location1 site (La Jolla, United States)
Project startJanuary 1, 2025
Project endNovember 30, 2029
Funding year2025
Award (this year)$772,581
NIH project number1R01AG090641-01
Project IDNIH-11029187 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults aged 21 and older who are diagnosed with Alzheimer's disease.

Less likely to help

Patients with other forms of dementia or those under 21 years old may not benefit from this research.

What this research studies

This research focuses on understanding how neurovascular dysfunction contributes to Alzheimer's disease. It examines the role of the Sox18 protein in the blood-brain barrier and how changes in blood vessel function may lead to the progression of Alzheimer's pathology. By analyzing blood vessels from patients with Alzheimer's and comparing them to healthy controls, the study aims to uncover molecular changes that affect blood flow and brain health. This could provide insights into potential therapeutic targets for improving brain function in Alzheimer's patients.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve blood flow and reduce neurodegeneration in Alzheimer's disease.

How similar studies have gone: Previous research has shown that targeting neurovascular dysfunction can lead to improvements in Alzheimer's disease models, suggesting a promising avenue for further exploration.

Where this research is happening

  • University of California, San Diego
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Daneman, Richard — University of California, San Diego
  • Study coordinator: Daneman, Richard

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.